RS
Robeco Schweiz’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-16,300
| Closed | -$436K | – | 162 |
|
2019
Q2 | $436K | Buy |
16,300
+1,180
| +8% | +$31.6K | 0.02% | 135 |
|
2019
Q1 | $502K | Buy |
15,120
+2,820
| +23% | +$93.6K | 0.02% | 137 |
|
2018
Q4 | $352K | Buy |
12,300
+9,300
| +310% | +$266K | 0.02% | 138 |
|
2018
Q3 | $139K | Sell |
3,000
-1,193
| -28% | -$55.3K | 0.01% | 160 |
|
2018
Q2 | $156K | Buy |
4,193
+1,193
| +40% | +$44.4K | 0.01% | 157 |
|
2018
Q1 | $89K | Hold |
3,000
| – | – | ﹤0.01% | 165 |
|
2017
Q4 | $104K | Hold |
3,000
| – | – | 0.01% | 163 |
|
2017
Q3 | $109K | Hold |
3,000
| – | – | 0.01% | 168 |
|
2017
Q2 | $77K | Hold |
3,000
| – | – | 0.01% | 177 |
|
2017
Q1 | $57K | Hold |
3,000
| – | – | ﹤0.01% | 183 |
|
2016
Q4 | $50K | Sell |
3,000
-47,934
| -94% | -$799K | ﹤0.01% | 188 |
|
2016
Q3 | $1.05M | Buy |
+50,934
| New | +$1.05M | 0.09% | 128 |
|